Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection

Journal of Immunology

Volumn 168, Issue 4, 2002, Pages 1600-1609

  Guillot, Cécile ^a   Guillonneau, Carole ^a   Mathieu, Patrick ^a   Gerdes, Christian A ^a   Ménoret, Séverine ^a   Braudeau, Cécile ^a   Tesson, Laurent ^a   Renaudin, Karine ^a   Castro, Maria G ^a   Löwenstein, Pedro R ^a   Anegon, Ignacio ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; CD4 ANTIGEN; CD40 ANTIGEN; CD40 IMMUNOGLOBULIN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD8 ANTIGEN; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; GENE TRANSFER; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; IMMUNE RESPONSE; IMMUNOHISTOLOGY; LEUKOCYTE; LIGAND BINDING; LONG TERM CARE; MACROPHAGE; MALE; MAST CELL; MIXED LYMPHOCYTE REACTION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE SUBPOPULATION; VASCULAR DISEASE;

EID: 0037083278     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.4.1600     Document Type: Article

References (45)

1. Improved graft survival after renal transplantation in the United States, 1988 to 1996
2. Chronic rejection
3. Gene therapy in transplantation in the year 2000: Moving towards clinical applications?
4. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes
5. Adenovirus-mediated gene transfer in the transplant setting. II. Successful expression of transferred cDNA in syngeneic liver grafts
6. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model: Immunosuppression with TGF-β1 or vIL-10
7. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen
8. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig
9. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression
10. CD40:CD154 interactions and allograft survival
11. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
12. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
13. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand
14. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo
15. + T cell tolerance and linked suppression
16. + T cells play a critical role in costimulation blockade-resistant allograft rejection
17. + T cells can trigger allograft rejection
18. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
19. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
20. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154
21. Tolerance and chronic rejection
22. Challenges for the clinical application of transplant tolerance strategies
23. + T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade
24. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis
25. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation
26. Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human γ1
27. CD40 ligand-transduced co-stimulation of T cells in the development of helper function
28. Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo
29. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials
30. Anti-adenovirus immune responses in rats are enhanced by interleukin-4 but not interleukin-10 produced by recombinant adenovirus
31. Factors influencing recombinant adeno-associated virus production
32. A critical role for transforming growth factor-β (TGF-β) in donor transfusion-induced allograft tolerance
33. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection
34. + T lymphocytes and IFNγ
35. Mast cells in acute and chronic rejection of rat cardiac allografts: A major source of basic fibroblast growth factor
36. Targeting signal I through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant model
37. Dendritic cells and the control of immunity
38. CD40-gp39 interactions play a critical role during allograft rejection: Suppression of allograft rejection by blockade of the CD40-gp39 pathway
39. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation
40. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver
41. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors
42. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle
43. CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40
44. Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions
45. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction